Archive | Beauty Meets Science Blog

Dr. Bass’ Blog

COVID-19 Update March 20, 2020

March 20, 2020 To all my patients: I am writing to update you on the status of clinical services at Bass Plastic Surgery in the midst of the blossoming Corona virus epidemic in New York. Based on New York State Department of Health and professional medical society recommendations, all elective surgery had been cancelled earlier this […]

Continue Reading

Belotero: Special features for this new filler

Belotero is a hyaluronate filler, like Restylane and Juvederm, which has very recently become widely available in the United States.  Experience with use in Europe for the past few years tells us a lot about where it will fit in with other available filler treatments here in the U.S. Also, since a select group of physicians including Dr. Bass have […]

Continue Reading

Interdisciplinary Brainstorming on Beauty Technologies – The Summit in Aesthetic Medicine 2012

I am back from the Summit in Aesthetic Medicine, the annual meeting  I co-chair with Dr. Christropher Zachary, the Chairman of Dermatology at University of California, Irvine.  This is a meeting attended by plastic surgeons, facial plastic surgeons, oculoplastic surgeons and dermatologists – the “core four” specialties that receive training in aesthetic surgery and medicine during […]

Continue Reading

CoolSculpting is cleared by FDA for abdominal fat reduction

The CoolSculpting treatment has just received clearance from the Food and Drug Administration (FDA) for abdominal fat reduction.  The treatment, which used cold to selectively damage and remove fat cells, had been previously cleared for noninvasive fat layer reduction in the flank or love handle area.  What does this new clearance mean for doctors and patients?  […]

Continue Reading

Belotero -New Filler is FDA Approved

In December 2011, the FDA approved Belotero, an injectable filler manufactured by Merz Aesthetics, for the treatment of moderate to severe facial folds, like nasolabial folds.  Several hyaluronate fillers have been added to the US marketplace since the initial approval of Restylane in 2004.  Each hyaluronate filler is based on the same basic building block […]

Continue Reading

“No Recovery” Gets Its Semantics Straight -Courtesy of ASAPS

How often do you hear about “no recovery” or “lunchtime” treatments when reading about plastic surgery in the media?  Companies are trying to provide what the public wants: quick, low-risk, low- or no-recovery aesthetic treatments.  But when these so call “no-recovery”  treatments fall short of these goals, the word doesn’t always get out there.  Many […]

Continue Reading

Zeltiq Goes Public

Zeltiq Aesthetics Inc. completed their IPO and is now a publicly traded company. Zeltiq is the manufacturer and markets the CoolSculpting system, the first clinically effective non-invasive fat reduction system. What does this business event mean for doctors and patients? The big benefits stem from the new large influx of money, which will allow the company to put […]

Continue Reading